Nebulised surfactant in preterm infants with or at risk of respiratory distress syndrome
Nebulised surfactant has the potential to deliver surfactant to the infant lung with the goal of avoiding endotracheal intubation and ventilation, ventilator-induced lung injury and bronchopulmonary dysplasia (BPD). To determine the effect of nebulised surfactant administration either as prophylaxis or treatment compared to placebo, no treatment or intratracheal surfactant administration on morbidity and mortality in preterm infants with, or at risk of, respiratory distress syndrome (RDS)....[Show more]
|Collections||ANU Research Publications|
|Source:||Cochrane Database of Systematic Reviews (CDSR)|
|01_Mohamed_Nebulised_surfactant_in_2012.pdf||321.67 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.